A61K 49/0097
Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or
Official title: {Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo}
A61K49/0097 (Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or) appears on 91 US grants and 157 published applications in this corpus.
Search patents in A61K- Granted patents
- 91
- Published applications
- 157
- Assignees
- 93
- Inventors
- 300
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 4 |
| 2004 | 1 | 2 |
| 2005 | 0 | 6 |
| 2006 | 0 | 3 |
| 2007 | 3 | 4 |
| 2008 | 0 | 5 |
| 2009 | 1 | 12 |
| 2010 | 1 | 12 |
| 2011 | 4 | 2 |
| 2012 | 4 | 6 |
| 2013 | 7 | 5 |
| 2014 | 4 | 8 |
| 2015 | 11 | 9 |
| 2016 | 4 | 7 |
| 2017 | 5 | 11 |
| 2018 | 6 | 11 |
| 2019 | 6 | 9 |
| 2020 | 3 | 4 |
| 2021 | 6 | 9 |
| 2022 | 5 | 4 |
| 2023 | 1 | 9 |
| 2024 | 3 | 4 |
| 2025 | 5 | 3 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Methods of suppressing delivery of exosomes to liver and spleen12 May 2026US 12,622,876 B2Lonza Sales AG
- Methods for monitoring physiological status of a body organ24 Mar 2026US 12,584,904 B2BioCrine AB
- M13 phage based gene therapy platform4 Nov 2025US 12,458,674 B2Massachusetts Institute of Technology
- Systems and methods for imaging animals24 Sep 2026US 2026/0284232 A1Arizona Board of Regents on Behalf of the University of Arizona
- Isolated targeted delivery system for the treatment of ovarian cancer23 Jul 2026US 2026/0207519 A1
- Gene constructs encoding fusion proteins having binding capacity for strep-tag binding substances, and expression vectors, recombinant strains and anticancer compositions comprising the same9 Jul 2026US 2026/0193299 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- Isolated targeted delivery system for the treatment of glioma2 Apr 2026US 2026/0091119 A1
- Compositions and methods for selective phagocytosis of human cancer cells5 Feb 2026US 2026/0035663 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Process for identifying cancerous and/or metastatic cells of a living organism76US 7,244,232 B2Biomed Solutions, LLC · 2007
- Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation75US 6,351,663 B1Akorn, Inc. · 2002
- In vivo cellular tracking64US 4,762,701 ASmithKline Beckman Corporation · 1988
- Metastasis models using green fluorescent protein (GFP) as a marker58US 6,251,384 B1AntiCancer, Inc. · 2001
- Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging50US 8,361,775 B2Novadaq Technologies Inc. · 2013